A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

Diagnosed with small-cell lung cancer at 28, Montessa Lee has defied the odds for nearly 20 years, surviving a disease with a ...

His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Introduction Over 100 000 service users are admitted to acute mental health wards annually, many involuntarily. Wards are under incredible pressure due to high bed occupancy rates and staff shortages.

Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to ...

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is ...

COLUMBUS, Ohio — Corinne Johnson is passionate about caring, not just for her patients, but also for her peers. OSU Wexner Medical Center nurse says nurses experience two different types of workplace ...

More than 28% of lung cancers were detected early, when survival rates are better — a 12% improvement over five years. Also, ...

Cannabidiol (CBD) inhibits tumor growth in triple-negative breast cancer (TNBC), a highly aggressive form that lacks targeted ...

Nuvalent is approaching the precipice of a first targeted therapy approval in lung cancer. Click here to read why NUVL stock ...